Logo image of CRGE

CHARGE ENTERPRISES INC (CRGE) Stock Fundamental Analysis

NASDAQ:CRGE - Nasdaq - US1596101048 - Common Stock - Currency: USD

0.0288  -0.03 (-52%)

After market: 0.0278 0 (-3.47%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CRGE. CRGE was compared to 33 industry peers in the Diversified Telecommunication Services industry. The financial health of CRGE is average, but there are quite some concerns on its profitability. CRGE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CRGE had negative earnings in the past year.
In the past year CRGE had a positive cash flow from operations.
CRGE had negative earnings in each of the past 5 years.
CRGE had a negative operating cash flow in each of the past 5 years.
CRGE Yearly Net Income VS EBIT VS OCF VS FCFCRGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

CRGE has a worse Return On Assets (-22.08%) than 89.19% of its industry peers.
Looking at the Return On Equity, with a value of -95.02%, CRGE is doing worse than 89.19% of the companies in the same industry.
Industry RankSector Rank
ROA -22.08%
ROE -95.02%
ROIC N/A
ROA(3y)-38.85%
ROA(5y)N/A
ROE(3y)-199.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRGE Yearly ROA, ROE, ROICCRGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -100 -200

1.3 Margins

CRGE has a worse Gross Margin (4.84%) than 94.59% of its industry peers.
CRGE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRGE Yearly Profit, Operating, Gross MarginsCRGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -10 -20 -30 -40

More info and screens

4

2. Health

2.1 Basic Checks

CRGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRGE has been increased compared to 1 year ago.
The debt/assets ratio for CRGE has been reduced compared to a year ago.
CRGE Yearly Shares OutstandingCRGE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 50M 100M 150M 200M
CRGE Yearly Total Debt VS Total AssetsCRGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

CRGE has an Altman-Z score of 1.36. This is a bad value and indicates that CRGE is not financially healthy and even has some risk of bankruptcy.
CRGE has a Altman-Z score of 1.36. This is amongst the best in the industry. CRGE outperforms 81.08% of its industry peers.
The Debt to FCF ratio of CRGE is 1.50, which is an excellent value as it means it would take CRGE, only 1.50 years of fcf income to pay off all of its debts.
CRGE's Debt to FCF ratio of 1.50 is amongst the best of the industry. CRGE outperforms 91.89% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that CRGE is somewhat dependend on debt financing.
CRGE's Debt to Equity ratio of 0.63 is fine compared to the rest of the industry. CRGE outperforms 70.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 1.5
Altman-Z 1.36
ROIC/WACCN/A
WACC8.03%
CRGE Yearly LT Debt VS Equity VS FCFCRGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 0.94 indicates that CRGE may have some problems paying its short term obligations.
CRGE has a Current ratio (0.94) which is comparable to the rest of the industry.
CRGE has a Quick Ratio of 0.94. This is a bad value and indicates that CRGE is not financially healthy enough and could expect problems in meeting its short term obligations.
CRGE has a Quick ratio of 0.93. This is comparable to the rest of the industry: CRGE outperforms 48.65% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.93
CRGE Yearly Current Assets VS Current LiabilitesCRGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

CRGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.05%, which is quite impressive.
CRGE shows a decrease in Revenue. In the last year, the revenue decreased by -1.21%.
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)-1.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-28.85%

3.2 Future

The Earnings Per Share is expected to grow by 16.96% on average over the next years. This is quite good.
CRGE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.49% yearly.
EPS Next Y48.57%
EPS Next 2Y33.1%
EPS Next 3Y16.96%
EPS Next 5YN/A
Revenue Next Year-15.65%
Revenue Next 2Y-5.97%
Revenue Next 3Y-2.49%
Revenue Next 5YN/A

3.3 Evolution

CRGE Yearly Revenue VS EstimatesCRGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 200M 400M 600M
CRGE Yearly EPS VS EstimatesCRGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRGE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CRGE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRGE Price Earnings VS Forward Price EarningsCRGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

CRGE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRGE is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.33
EV/EBITDA N/A
CRGE Per share dataCRGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

CRGE's earnings are expected to grow with 16.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.1%
EPS Next 3Y16.96%

More info and screens

0

5. Dividend

5.1 Amount

CRGE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHARGE ENTERPRISES INC

NASDAQ:CRGE (2/28/2024, 8:27:57 PM)

After market: 0.0278 0 (-3.47%)

0.0288

-0.03 (-52%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)11-08 2023-11-08/bmo
Earnings (Next)03-26 2024-03-26/amc
Inst Owners0.02%
Inst Owner Change0%
Ins Owners15.25%
Ins Owner Change0%
Market Cap6.19M
Analysts43.33
Price Target3.83 (13198.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-3.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.93%
Min EPS beat(2)18.3%
Max EPS beat(2)21.57%
EPS beat(4)3
Avg EPS beat(4)2.35%
Min EPS beat(4)-60.43%
Max EPS beat(4)29.97%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.26%
Min Revenue beat(2)-20.72%
Max Revenue beat(2)-9.8%
Revenue beat(4)1
Avg Revenue beat(4)-10.76%
Min Revenue beat(4)-20.72%
Max Revenue beat(4)0.96%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.33
P/OCF 0.33
P/B 0.14
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.09
FCFY300.27%
OCF(TTM)0.09
OCFY303.22%
SpS2.98
BVpS0.2
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.08%
ROE -95.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.84%
FCFM 2.9%
ROA(3y)-38.85%
ROA(5y)N/A
ROE(3y)-199.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover3.42
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 1.5
Debt/EBITDA N/A
Cap/Depr 2.23%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.93
Altman-Z 1.36
F-Score5
WACC8.03%
ROIC/WACCN/A
Cap/Depr(3y)170.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.19%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y48.57%
EPS Next 2Y33.1%
EPS Next 3Y16.96%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-28.85%
Revenue Next Year-15.65%
Revenue Next 2Y-5.97%
Revenue Next 3Y-2.49%
Revenue Next 5YN/A
EBIT growth 1Y11.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.53%
EBIT Next 3Y27.17%
EBIT Next 5YN/A
FCF growth 1Y575.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y869.63%
OCF growth 3YN/A
OCF growth 5YN/A